Tocilizumab and COVID-19: Timing of administration assessment.
Richier Q, Jachiet V, Bonnemains V, Plaçais L, Abisror N, Garnier M, Pacanowski J, Dhote R, Hinchschberger O, Michel M, Bienvenu B, Comarmond C, Lacombe K, Mekinian A.
Richier Q, et al.
Infect Dis Now. 2022 Feb;52(1):31-34. doi: 10.1016/j.idnow.2021.06.304. Epub 2021 Jun 29.
Infect Dis Now. 2022.
PMID: 34198000
Free PMC article.